PRENATAL GENETIC SCREENING

NIPT — Non-Invasive Prenatal Testing

A blood-based prenatal screening option that can help assess the chance of selected chromosome conditions, with clear guidance on panel scope and follow-up.

What NIPT can screen for

The conditions assessed depend on the chosen panel. We can help you confirm what is included before a sample is collected.

Trisomy 21

Screening for a chromosome pattern associated with Down syndrome.

Trisomy 18

Screening for a chromosome pattern associated with Edwards syndrome.

Trisomy 13

Screening for a chromosome pattern associated with Patau syndrome.

Other panel options

Some panels include sex chromosome screening; confirm what is offered before testing.

NIPT at a glance

10 weeks

Earliest screening

NIPT may be available from around 10 weeks of pregnancy, subject to clinical guidance.

99%+

High detection rate

Reported performance varies by condition and panel. NIPT is a screening test, not a diagnosis.

Low

False-positive rate

A higher-chance screening result needs follow-up with a qualified clinician.

5–7 days

Typical turnaround

Timing depends on sample receipt, the panel selected and laboratory workflow.

Frequently asked questions

No. NIPT is a screening test that estimates the chance of selected chromosome conditions. A clinician can explain what a result means and whether diagnostic testing should be considered.
Timing depends on the pregnancy and the specific panel. Please discuss the appropriate testing window with your obstetric or genetics team before booking.
A higher-chance screening result is not a diagnosis. Your clinician can discuss confirmatory testing and other appropriate follow-up options.
Panel scope varies. Ask EmbryoGenomics or your clinician to confirm which conditions are included in the available test before sample collection.

Screen with clear guidance

Speak with our team about NIPT options and the questions to discuss with your care provider.